Skip to content
Open access

Brain Tumor Classification Using a Hybrid Learning Strategy Integrating GAN-Augmented Neural Networks

Aug 2026 · International Journal of Online and Biomedical Engineering (iJOE) · 0 citations

TL;DR

A hybrid framework that combines generative adversarial networks (GANs), convolutional neural networks (CNNs), and Vision Transformers (ViTs) for accurate tumor classification demonstrates the potential of advanced DL models to strengthen MRI-based tumor diagnosis and support more reliable clinical decision-making.

Abstract

Brain tumor (BT) classification plays a vital role in computer-aided diagnosis, as early detection directly influences treatment planning and patient survival. Advances in artificial intelligence, particularly in machine learning (ML) and deep learning (DL), have greatly improved automated tumor identification from magnetic resonance imaging (MRI), reducing reliance on manual assessment. This study proposes a hybrid framework that combines generative adversarial networks (GANs), convolutional neural networks (CNNs), and Vision Transformers (ViTs) for accurate tumor classification. GANs are used to generate realistic synthetic MRI images, addressing data scarcity and increasing dataset diversity. CNNs extract discriminative deep features, accelerating training while limiting overfitting. These features are then processed by a ViT model, capable of capturing complex spatial relationships within medical images. Experimental results show that the proposed ViT–CNN–GAN approach achieves 97.36% accuracy, outperforming conventional methods. Overall, this framework demonstrates the potential of advanced DL models to strengthen MRI-based tumor diagnosis and support more reliable clinical decision-making.

Read PDF

Similar papers

Conference Aug 2026

BrainTumor CNN: brain tumor classification via transfer learning and ResNet-18

This study proposes BrainTumor CNN, a convolutional neural network (CNN) for classifying brain tumor MRI images, which leverages transfer learning via a pre-trained ResNet-18 network, integrating data augmentation and Dropout regularization to enhance robustness and generalization.

Yicheng Xu · 0 citations
Open access Jul 2026

Xception-Based Brain Tumor Classification with GAN Augmentation and Multi-Technique Explainable AI

Automated brain tumor classification is essential for early detection and treatment planning. This study addresses the critical gap in Bangladeshi population-specific diagnostic systems by developing a comprehensive framework that integrates Generative Adversarial Network (GAN)-based augmentation with deep transfer learning and explainable artificial intelligence for MRI-based brain tumor classification. The proposed approach utilizes the PMRAM dataset comprising 3,505 T1-weighted MRI images from Bangladeshi patients across four classes (glioma, meningioma, pituitary tumor, and normal). A custom deep convolutional GAN generates 300 synthetic images per class, resulting in 40% dataset augmentation. The Xception architecture with ImageNet pre-training is employed using a two-stage training strategy consisting of feature extraction followed by fine-tuning of the final 100 layers. Stratified 5-fold cross-validation is conducted to compare performance against DenseNet169, MobileNetV2, and InceptionV3, while multi-technique explainable AI (GradCAM++, Score-CAM, SHAP, and LIME) provides clinical interpretability. Quantitative XAI evaluation via attribution map IoU and deletion faithfulness metrics confirms that highlighted regions are decision-critical and spatially concordant. Experimental results show that the proposed Xception-based model achieves a mean accuracy of 98.08% ± 0.42%, outperforming DenseNet169 (97.66%), MobileNetV2 (97.40%), and InceptionV3 (96.98%). The model attains a mean AUC of 0.997 with an Expected Calibration Error of 0.0135, and statistical validation confirms significance (p = 0.036). Ablation studies further demonstrate the contributions of GAN augmentation (+3.33%), fine tuning (+6.88%), and transfer learning (+21.81%). The proposed framework provides a comprehensive benchmark for Bangladeshi brain tumor classification with accuracy approaching clinical grade performance and interpretable predictions, highlighting the effectiveness of GAN-based transfer learning for population specific medical AI systems.

S. M. Tawhid, Yash Rohan, Shochi Akter et al. · 0 citations
Open access Aug 2026

Brain Tumor Classification in MRI Images Using Convolutional Neural Networks with Explainable Artificial Intelligence

Brain tumors are a condition requiring rapid and accurate diagnosis. This study aims to enhance the transparency of Convolutional Neural Network (CNN)-based brain tumor classification models by implementing Explainable Artificial Intelligence (XAI) techniques, specifically Eigen-CAM and LIME. The models were developed using a transfer learning approach on ResNet50 and EfficientNetB0 architectures, utilizing a dataset of 3,000 MRI images categorized into glioma, meningioma, and pituitary tumor classes. Test results indicate that ResNet50 achieved the best performance, with accuracy, precision, recall, and F1-score values of 94%, while EfficientNetB0 achieved 93%. The application of 5-fold cross-validation improved the models' generalization capabilities and reduced the risk of overfitting. Visualizations using Eigen-CAM and LIME demonstrate that the models focus on relevant tumor regions, thereby increasing the transparency and reliability of MRI-based classification.

Muhammad Abdul Ghofur, Nirma Ceisa Santi, Hastie Audytra · 0 citations
Open access 2026

Accurate Brain Tumor Classification Using MRI Images Based on A Hybrid Vision Transformer and BiLSTM Framework

Results show that ViT–BiLSTM's classification performance is superior to those of traditional deep learning methods: among all the tumor categories its accuracy is higher, its fine-tuning more perfect, as well as, its Recall rates greater.

Nagham Salim Mohammed, Omar S. Almolaa, A. S. Abdullah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.